secwatch.observer — SEC 8-K summary
======================================

Issuer:     GE HealthCare Technologies Inc. (GEHC)
CIK:        0001932393
Form:       8-K
Filed at:   2025-02-13T23:59:59+00:00
Accession:  0001932393-25-000004
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GE HealthCare reports Q4 EPS $1.57, adjusted EPS $1.45; guides FY2025 adjusted EPS $4.61-$4.75
--------------------------------------------------------------------------------

- Q4 revenue $5.3B, up 2% organic; net income $720M (13.5% margin) vs $403M (7.7%).
- Diluted EPS $1.57 vs $0.88; Adjusted EPS $1.45 vs $1.18; Adjusted EBIT margin 18.7% vs 16.1%.
- FY2024 revenue $19.7B (+1% organic); net income $2.0B; diluted EPS $4.34; Adjusted EPS $4.49.
- FY2025 guidance: organic revenue growth 2-3%; adjusted EBIT margin 16.7-16.8%; adjusted EPS $4.61-$4.75.
- Segment highlights: Advanced Visualization Solutions (+4% organic) and Pharmaceutical Diagnostics (+9%) grew; China weakness noted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1932393/000193239325000004/0001932393-25-000004-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1932393/000193239325000004/gehc-20250213.htm
  HTML page:      https://secwatch.observer/filing/0001932393-25-000004

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer